Patent details

EP3661520 Title: ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT

Basic Information

Publication number:
EP3661520
PCT Application Number:
EP2018054470
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187056635
PCT Publication Number:
WO2019025031
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT
French Title of Invention:
THÉRAPIE ADJUVANTE DESTINÉE AU TRAITEMENT DU CANCER DE LA PROSTATE
German Title of Invention:
ADJUVANTIENTHERAPIE ZUR VERWENDUNG BEI DER BEHANDLUNG VON PROSTATAKREBS
SPC Number:

Dates

Filing date:
23/02/2018
Grant date:
01/12/2021
EP Publication Date:
10/06/2020
PCT Publication Date:
07/02/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2021
EP B1 Publication Date:
01/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/02/2022
Expiration date:
23/02/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/11/2021
 
 

Name:
Fund SA
Address:
Rue Saint Georges 5, 4000 Liège, Belgium (BE)

Inventor

Name:
DEBRUYNE, F.M.J.
Address:
Netherlands (NL)

Priority

Priority Number:
17184320
Priority Date:
01/08/2017
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/565; A61K 45/06; A61K 9/00; A61P 35/00; A61P 35/04;

Publication

European Patent Bulletin

Issue number:
202148
Publication date:
01/12/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages